MedPath

The effect of metacognitive therapy in patient with schizophrenia

Not Applicable
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT2016110330678N1
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Age 18 to 45 years; diagnosis of schizophrenia according to The Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 is approved by the psychiatrist's interview; Be educated at least secondary school (8 years); The patient has positive symptoms (symptoms are moderate to high in the initial tests); no change in medication over the past month and in the last two months has not received ECT; patient's condition is stable and no acute psychosis
Exclusion criteria: Borderline intellectual functioning or mental retardation based on the history and interviews; Drug or alcohol; Severe neurological disease (epilepsy, Parkinson's, dementia, Multiple sclerosis and any movement disorder); Forms of thought disorder, Hostility and extreme aggression; In case of worsening of symptoms or need to change the medication

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positive symptoms. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PANSS and PSYRATS scale.;Negative symptoms. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PANSS scale.;Dimensions of delusions and hallucinations. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PDI questionnaire.;Insight. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: BIS scale.;Quality of life. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: QOLI questionnaire.;Global Functioning. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: Global Assessment of Functioning.
Secondary Outcome Measures
NameTimeMethod
Satisfaction with treatment. Timepoint: After the intervention, three months and six months after intervention. Method of measurement: Treatment Satisfaction Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath